Long-term survival in metastatic malignant struma ovarii treated with oral chemotherapy: A case report

Oncology Letters

Volumn 8, Issue 6, 2014, Pages 2458-2462

  Ukita, Masayo ^a   Nakai, Hidekatsu ^a   Kotani, Yasushi ^a   Tobiume, Takako ^a   Koike, Eiji ^a   Tsuji, Isao ^a   Suzuki, Ayako ^a   Mandai, Masaki ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Long term survival; Malignant struma ovarii; Metastasis

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; PACLITAXEL; UFT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG SUBSTITUTION; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; SALPINGOOOPHORECTOMY; TERATOMA; THORAX RADIOGRAPHY; WEDGE RESECTION;

EID: 84908019130     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2587     Document Type: Article

References (16)

1. 131I therapy: focus on preservation of fertility and selected review of the literature. Gynecol Endocrinol 24: 312-319, 2008.
2. 131 therapy. Gynecol Oncol 89: 543-548, 2003.
3. Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS and Kim HS: Clinical characteristics of struma ovarii. J Gynecol Oncol 19: 135-138, 2008.
4. Devaney K, Snyder R, Norris HJ and Tavassoli FA: Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 12: 333-343, 1993.
5. Steinman RA, De Castro IO, Shrayyef M, Chengazi V, Giampoli E, Van Der Sloot P, Calvi LM, et al: Two cases of malignant struma ovarii with metastasis to pelvic bone. Gynecol Obstet Invest 75: 139-144, 2013.
6. Dardik RB, Dardik M, Westra W and Montz FJ: Malignant struma ovarii: two case reports and a review of the literature. Gynecol Oncol 73: 447-451, 1999.
7. Heintz AP, Odicino F, Maisonneuve P, et al: Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological cancer. Int J Gynaecol Obstet 95 (Suppl 1): S161-S192, 2006.
8. Zakhem A, Aftimos G, Kreidy R and Salem P: Malignant struma ovarii: report of two cases and selected review of the literature. J Surg Oncol 43: 61-65, 1990.
9. Robboy SJ, Shaco-Levy R, Peng RY, Snyder MJ, Donahue J, Bentley RC, Bean S, et al: Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol 28: 405-422, 2009.
10. Makani S, Kim W and Gaba AR: Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol 94: 835-839, 2004.
11. Hatami M, Breining D, Owers RL, Del Priore G and Goldberg GL: Malignant struma ovarii - a case report and review of the literature. Gynecol Obstet Invest 65: 104-107, 2008.
12. Passler C, Scheuba C, Prager G, Kaczirek K, Kaserer K, Zetting G and Niederle B: Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 11: 131-139, 2004.
13. Vadmal MS, Smilari TF, Lovecchio JL, Klein IL and Hajdu SI: Diagnosis and treatment of disseminated struma ovarii with malignant transformation. Gynecol Oncol 64: 541-546, 1997.
14. Brenner W, Bohuslavizki KH, Wolf H, Sippel C, Clausen M and Henze E: Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Eur J Nucl Med 23: 91-94, 1996.
15. Pardo-Mindan FJ and Vazquez JJ: Malignant struma ovarii. Light and electron microscopic study. Cancer 51: 337-343, 1983.
16. Sherman SI: Targeted therapy of thyroid cancer. Biochem Pharmacol 80: 592-601, 2010.